DK0652903T3 - New human recombinant gamma interferon - Google Patents

New human recombinant gamma interferon

Info

Publication number
DK0652903T3
DK0652903T3 DK92900077.6T DK92900077T DK0652903T3 DK 0652903 T3 DK0652903 T3 DK 0652903T3 DK 92900077 T DK92900077 T DK 92900077T DK 0652903 T3 DK0652903 T3 DK 0652903T3
Authority
DK
Denmark
Prior art keywords
human recombinant
gamma interferon
concerns
new human
new
Prior art date
Application number
DK92900077.6T
Other languages
Danish (da)
Inventor
Otto Slodowski
Joachim Boehm
Bernd Otto
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of DK0652903T3 publication Critical patent/DK0652903T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The invention concerns a new mutant of $g(g)-IFN. This new polypeptide contains 134 amino acids. Amino acids 1 to 132 are the same as those of natural $g(g)-interferon. The first amino acid, methionine, in the zero position is also present, as has been demonstrated by protein sequencing. The amino acid in position 133 is leucine instead of glutamine. The invention also concerns DNA sequences and plasmid DNA (DSM 6238) which codes for this new polypeptide. The invention further concerns the use of the polypeptide as a drug as well as its use as a fine-chemical reagent for $i(in vitro) experiments.
DK92900077.6T 1990-11-19 1991-11-14 New human recombinant gamma interferon DK0652903T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036856A DE4036856C1 (en) 1990-11-19 1990-11-19

Publications (1)

Publication Number Publication Date
DK0652903T3 true DK0652903T3 (en) 1998-03-30

Family

ID=6418557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900077.6T DK0652903T3 (en) 1990-11-19 1991-11-14 New human recombinant gamma interferon

Country Status (9)

Country Link
EP (1) EP0652903B1 (en)
JP (1) JP3219274B2 (en)
AT (1) ATE163651T1 (en)
AU (1) AU9026691A (en)
CA (1) CA2096532C (en)
DE (2) DE4036856C1 (en)
DK (1) DK0652903T3 (en)
ES (1) ES2114555T3 (en)
WO (1) WO1992008737A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535853C2 (en) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Variants of recombinant human interferon gamma, process for their preparation and their use
DE19604583C2 (en) * 1996-02-08 1999-11-18 Fraunhofer Ges Forschung Process for the synthesis of soluble, recombinant proteins from bacterial cells
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
CN1309423C (en) 1999-11-12 2007-04-11 马克西根控股公司 Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
JP2005518183A (en) * 2001-04-06 2005-06-23 マキシゲン・ホールディングズ・リミテッド Interferon gamma polypeptide variant
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
WO2004005341A2 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
CA3115082A1 (en) 2018-10-11 2020-04-16 Inhibrx, Inc. B7h3 single domain antibodies and therapeutic compositions thereof
CN113518647A (en) 2018-10-11 2021-10-19 印希比股份有限公司 5T4 single domain antibodies and therapeutic compositions thereof
US20210380679A1 (en) 2018-10-11 2021-12-09 Inhibrx, Inc. Dll3 single domain antibodies and therapeutic compositions thereof
EP3864049A1 (en) 2018-10-11 2021-08-18 Inhibrx, Inc. Pd-1 single domain antibodies and therapeutic compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (en) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd Novel human interferon-gamma polypeptide derivative
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3730331A1 (en) * 1987-09-10 1989-03-30 Basf Ag NEW POLYPEPTIDES, METHOD FOR THE PRODUCTION THEREOF, THE VECTORS THEREFOR AND MEDICINAL PRODUCTS THEREOF

Also Published As

Publication number Publication date
ES2114555T3 (en) 1998-06-01
EP0652903A1 (en) 1995-05-17
CA2096532C (en) 2002-12-31
AU9026691A (en) 1992-06-11
DE4036856C1 (en) 1992-05-27
JPH06502992A (en) 1994-04-07
DE59108947D1 (en) 1998-04-09
WO1992008737A1 (en) 1992-05-29
ATE163651T1 (en) 1998-03-15
CA2096532A1 (en) 1992-05-20
EP0652903B1 (en) 1998-03-04
JP3219274B2 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
IT1153265B (en) POLYPEPTIDES CONTAINING THE SEQUENCE OF IMMUNE HUMAN INTERFERON AMINO ACIDS (HUMAN INTERFERONE RANGE), RELATED EXPRESSION VEHICLES, THEIR PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH POLYPEPTIDES
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
ES8802161A1 (en) Oligopeptides, intermediates and process for their preparation.
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DK0652903T3 (en) New human recombinant gamma interferon
AU669483B2 (en) Nucleotide sequences and resistance proteins cycloheximide
ES2009588A6 (en) Immunogenic recombinant yeast expression product and method for purifying it.
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
EP0330700A4 (en) Human prourokinase-like polypeptide.
ATE53606T1 (en) RECOMBINANT PLASMID INSERTED WITH A HERPES SIMPLEX VIRUS GENE.
DE3751398D1 (en) Substrate peptides.
EP0238275A3 (en) Recombinant product